select search filters
briefings
roundups & rapid reactions
before the headlines
Fiona fox's blog
Today, Moderna have published in a press release their interim top-line findings looking at antibody responses from their Omicron-containing bivalent COVID-19 vaccine.
Journalists dialled into the briefing to hear from Moderna scientists and ask them questions.
This was interim early data with no paper or preprint.
Speakers included:
Dr Philip Cruz, UK Medical Director, Moderna
Dr Paul Burton, Chief Medical Officer, Moderna
This Briefing was accompanied by an SMC Roundup of Comments.